{"id":12794,"date":"2024-10-11T15:40:11","date_gmt":"2024-10-11T13:40:11","guid":{"rendered":"https:\/\/valintermed.com\/?p=12794"},"modified":"2024-10-11T15:40:11","modified_gmt":"2024-10-11T13:40:11","slug":"retikulogistiotsitoma","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/reticulologistiotsitoma\/","title":{"rendered":"Reticulohistiocytoma"},"content":{"rendered":"
<\/div>\n

Reticulohistiocytoma is a rare chronic disease belonging to the group of histiocytic neoplasias, characterized by the proliferation of reticulocytes and histiocytes. This lesion can be isolated or associated with systemic pathology, which includes various clinical manifestations, from localized forms to more serious multisystem diseases. It is important to consider that reticulohistiocytoma is usually observed in children and young adults, although it can occur at any age. Pathological changes can affect the skin, lymph nodes and internal organs, which complicates the diagnosis and requires a multilevel approach to evaluation.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n